ZyVersa Therapeutics(ZVSA)
LIGHTHOUSE POINT, FLPharmaceutical
Focus: ZyVersa Therapeutics is a publicly traded specialty pharmaceutical company focused on neurology-related indications, currently in early-stage clinical development with a minimal commercial footprint.
Profile data last refreshed 16h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About ZyVersa Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow ZyVersa Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from ZyVersa Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
2HPβCD
Diabetic Kidney DiseaseClinical Trials (1)
NCT06489340P2a Open Label Study to Evaluate 2-HPβCD in Subjects With Diabetic Kidney Disease
Phase 2Help build intelligence for ZyVersa Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.